EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Promising Therapeutic Strategies for Hematologic Malignancies: Innovations and Potential

Jan Jakub Lica iD, Bhaskar Pradhan iD, Kawthar Safi iD, Joanna Jakóbkiewicz-Banecka iD, Andrzej Hellmann

Molecules · 2024

DOI: 10.3390/molecules29174280 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2024. Verfasst von Jan Jakub Lica und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Science, Powiśle University, 80-214 Gdańsk, Poland. Hauptthemen laut MEDLINE: Hematologic Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Molecules (MDPI, Basel).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this review we explore innovative approaches in the treatment of hematologic cancers by combining various therapeutic modalities. We discuss the synergistic potential of combining inhibitors targeting different cellular pathways with immunotherapies, molecular therapies, and hormonal therapies. Examples include combining PI3K inhibitors with proteasome inhibitors, NF-κB inhibitors with immunotherapy checkpoint inhibitors, and neddylation inhibitors with therapies targeting the tumor microenvironment. Additionally, we discuss the potential use of small molecules and peptide inhibitors in hematologic cancer treatment. These multidimensional therapeutic combinations present promising strategies for enhancing treatment efficacy and overcoming resistance mechanisms. However, further clinical research is required to validate their effectiveness and safety profiles in hematologic cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsHumansImmunotherapyMolecular Targeted TherapyTumor MicroenvironmentAnimalsProteasome InhibitorsAntineoplastic Agents

Stichwörter der Autor:innen

NF-κB inhibitorsPI3K inhibitorshematologic cancersimmunotherapy checkpoint inhibitorsinnovative approachesneddylation inhibitorsproteasome inhibitorssmall moleculessynergistic potentialtherapeutic modalities

Substanzen

Proteasome InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Faculty of Health Science, Powiśle University, 80-214 Gdańsk, Poland.
  • Department of Biochemistry, Faculty of Pharmacy, Medical University of Warsaw, 02-097 Warsaw, Poland.
  • Department of Biochemistry and Clinical Chemistry, Faculty of Biology, Medical University of Warsaw, 02-097 Warsaw, Poland.
  • Department Medical Biology and Genetics, Faculty of Biology, University of Gdańsk, 80-308 Gdańsk, Poland.
  • Department of Hematology and Transplantology, Faculty of Medicine, Medical University of Gdańsk, 80-214 Gdańsk, Poland.

ORCID-Profile: Jan Jakub Lica, Bhaskar Pradhan, Kawthar Safi, Joanna Jakóbkiewicz-Banecka

Förderung

  • Molecules (MDPI, Basel)

Zitieren

APA

Lica, J. J., Pradhan, B., Safi, K., Jakóbkiewicz-Banecka, J., & Hellmann, A. (2024). Promising Therapeutic Strategies for Hematologic Malignancies: Innovations and Potential. Molecules. https://doi.org/10.3390/molecules29174280

Vancouver

Lica JJ, Pradhan B, Safi K, Jakóbkiewicz-Banecka J, Hellmann A. Promising Therapeutic Strategies for Hematologic Malignancies: Innovations and Potential. Molecules. 2024. doi:10.3390/molecules29174280

BibTeX
@article{Lica2024,
  author = {Lica, Jan Jakub and Pradhan, Bhaskar and Safi, Kawthar and Jakóbkiewicz-Banecka, Joanna and Hellmann, Andrzej},
  title = {Promising Therapeutic Strategies for Hematologic Malignancies: Innovations and Potential},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29174280}
}
Kostenlos starten →